Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in the irritable colon : I. Administration by single i.v

Sixty out-patients with acute or sub-acute irritable colon were randomly allocated to receive a single intravenous dose of 50 mg tiropramide, 50 mg trimebutine maleate or 10 mg octilonium bromide. Before and after injection, multiple colonic manometry was performed, monitoring tonus, intensity and f...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 4(1986), 7 vom: 11., Seite 445-56
1. Verfasser: Galeone, M (VerfasserIn)
Weitere Verfasser: Stock, F, Moise, G, Cacioli, D, Benazzi, E, Riva, A
Format: Aufsatz
Sprache:Italian
Veröffentlicht: 1986
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Clinical Trial Comparative Study English Abstract Journal Article Randomized Controlled Trial Benzoates Quaternary Ammonium Compounds octylonium 26095-59-0 Tyrosine mehr... 42HK56048U Trimebutine QZ1OJ92E5R tiropramide R7S0904CN2
LEADER 01000naa a22002652 4500
001 NLM039421929
003 DE-627
005 20231221145043.0
007 tu
008 231221s1986 xx ||||| 00| ||ita c
028 5 2 |a pubmed24n0132.xml 
035 |a (DE-627)NLM039421929 
035 |a (NLM)3960945 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a ita 
100 1 |a Galeone, M  |e verfasserin  |4 aut 
245 1 0 |a Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in the irritable colon  |b I. Administration by single i.v 
246 3 3 |a Valutazione clinica e strumentale per manometria colonica multipla di tiropramide, trimebutina ed ottilonio bromuro in pazienti con colon irritabile: I. Somministrazione in dose singola i.v 
264 1 |c 1986 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 25.04.1986 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Sixty out-patients with acute or sub-acute irritable colon were randomly allocated to receive a single intravenous dose of 50 mg tiropramide, 50 mg trimebutine maleate or 10 mg octilonium bromide. Before and after injection, multiple colonic manometry was performed, monitoring tonus, intensity and frequency of sinusoid contraction waves, transitories and vibrations, as well as the voluntary contraction capacity. Significant variations in tonus were not observed with any drug, but, while tiropramide left unmodified the voluntary contractile ability, a significant inhibition was observed with trimebutine and octilonium. The overall power of spontaneous colonic contractions did not vary significantly with tiropramide, whereas some decrease was observed with trimebutine, and a substantial one with octilonium. Moreover, while with tiropramide and, to a lesser extent, with trimebutine there was a significant redistribution of muscular power so as to increase phasic propulsion waves and to decrease the ineffective transitory and vibrational contractions, with octilonium only a decreased wave amplitude was recorded without alteration of the frequency of transient spasms. Based on these observations, tiropramide was evaluated as being at least as effective an antispasmodic as octilonium and at least as effective a synchronizer as trimebutine, while setting itself aside from both reference drugs as it was the only one to act contemporarily as both an antispasmodic and a synchronizer 
650 4 |a Clinical Trial 
650 4 |a Comparative Study 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 4 |a Randomized Controlled Trial 
650 7 |a Benzoates  |2 NLM 
650 7 |a Quaternary Ammonium Compounds  |2 NLM 
650 7 |a octylonium  |2 NLM 
650 7 |a 26095-59-0  |2 NLM 
650 7 |a Tyrosine  |2 NLM 
650 7 |a 42HK56048U  |2 NLM 
650 7 |a Trimebutine  |2 NLM 
650 7 |a QZ1OJ92E5R  |2 NLM 
650 7 |a tiropramide  |2 NLM 
650 7 |a R7S0904CN2  |2 NLM 
700 1 |a Stock, F  |e verfasserin  |4 aut 
700 1 |a Moise, G  |e verfasserin  |4 aut 
700 1 |a Cacioli, D  |e verfasserin  |4 aut 
700 1 |a Benazzi, E  |e verfasserin  |4 aut 
700 1 |a Riva, A  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)  |d 1995  |g 4(1986), 7 vom: 11., Seite 445-56  |w (DE-627)NLM023961570 
773 1 8 |g volume:4  |g year:1986  |g number:7  |g day:11  |g pages:445-56 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_121 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 4  |j 1986  |e 7  |b 11  |h 445-56